Supply Chain | March 30, 2023
Granules India inaugurates packaging facility in Virginia
The facility is over 79,000 square feet and is equipped with packaging lines
The facility is over 79,000 square feet and is equipped with packaging lines
Supply increase to help meet growing global demand
Virginia will be responsible for meeting client needs for both media and commercial analytics.
Granules Pharmaceuticals gets 5 observations from USFDA on completion of GMP inspection
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The inspection was conducted at Granules Pharmaceuticals Inc. (GPI) from July 31, 2023 to August 03, 2023
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
Granules now have a total of 53 ANDA approvals from USFDA
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
The ninth acquisition since 2018
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)